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INTRODUCTION
The malaria parasite Plasmodium falciparum and related apicomplexan parasites such as 2 Toxoplasma evolved from photosynthetic organisms and contain a remnant plastid known as an 3 apicoplast (Gardner, Williamson, & Wilson, 1991; Howe, 1992;  McFadden, Reith, Munholland, not unexpected, the dependence of a plastid on just a single PPR protein is unique and identifies 1 PPR1 as a good potential drug target.
RESULTS

1
A single apicoplast PPR protein present in both Plasmodium and Toxoplasma 2
Searches of the P. falciparum genome for genes encoding PPR proteins identified only two 3 genes, PfPPR1 (PF3D7_1406400 (PF14_0061)) and PfPPR2 (PF3D7_1233300 (PFL1605W)). 4 Both genes encode proteins with 10 PPR motifs, as predicted by TPRpred (Karpenahalli, Lupas, 5 & Söding, 2007) . PfPPR1 belongs to the P-class of PPR proteins, as the repeats all comprise 35 6 amino acids, and the final PPR motif is situated at the C-terminus of the protein. PfPPR2 may 7 belong to the PLS class, as its PPR elements are not located at its C-terminus. Orthologues of 8 both PfPPR1 and PfPPR2 were found in all Plasmodium species with no evidence of paralogues 9 created by lineage-specific gene duplications. 10 11 For a protein to be targeted to the apicoplast it must contain both a signal peptide and a plastid- 12 targeting sequence. PfPPR1 and PfPPR2 were analyzed by PlasmoAP and PlasMit for putative 13 apicoplast and/or mitochondrial localization signals (Bender, van Dooren, Ralph, McFadden, & 14 Schneider, 2003; Foth et al., 2003) . PfPPR1 analysis by PlasmoAP resulted in 3/4 positive tests 15 for a signal peptide and 5/5 positive tests for an apicoplast targeting peptide, while PlasMit gave 16 a prediction of 99% for not being mitochondrial. This is consistent with an overall strong 17 prediction that PfPPR1 traffics to the apicoplast. PlasmoAP analyses of PPR1 sequences from 18 other Plasmodium species similarly predicted that most have an apicoplast localization 19 ( Supplementary Table S1 ), the exceptions being those encoded on genomes with a high GC 20 content, where PlasmoAP is less accurate (Foth et al., 2003) . Alignments of PPR1 show that the 21 protein is well conserved across Plasmodium species ( Figure S1 ). PfPPR2 was predicted to lack 22 both a signal peptide and a mitochondrial targeting sequence so its location is unknown, but is 23 unlikely to be apicoplast targeted. 7 To test for the presence of PPRs more broadly in the Apicomplexa we searched for homologues 1 in Toxoplasma and Cryptosporidium. Analysis of the Toxoplasma genome using BLAST and 2 TPRPred, identified five PPR proteins. Only one protein (TGGT1_244050, TgPPR1) contained a 3 predicted signal peptide followed by a plastid-targeting sequence as analyzed by SignalP and 4 iPSORT (Bannai, Tamada, Maruyama, Nakai, & Miyano, 2002; Nielsen, 2017) . None of the 5 other four proteins was predicted to include a signal peptide. This indicates that there is only one 6 apicoplast targeted PPR protein in Toxoplasma, as is the case in Plasmodium spp. The 7 apicomplexan Cryptosporidium, which has lost the apicoplast, did not contain any genes 8 encoding PPR proteins. 9 To test for the localization of the PfPPR1 protein, we expressed recombinant PfPPR1 in 10 Escherichia coli, raised poly-clonal antisera in rabbits and used immunofluorescence 11 microscopy to locate this protein. The signal from cells stained with anti-PfPPR1 co-localized 12 with apicoplast-located GFP in the P. falciparum D10-ACP L parasite line (Waller, Reed, 13 Cowman, & McFadden, 2000) ( Figure 1 ). This confirmed the predicted apicoplast-localization 14 of PfPPR1. A Western blot of P. falciparum lysate probed with the anti-PfPPR1 antibody 15 showed no detectable band, presumably due to low expression of the endogenous protein. 
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To test for the localization of the Toxoplasma TgPPR1, a 3'-PPR1-mCherry fusion construct was 1 created to tag the endogenous TgPPR gene. A Western blot probed with antibodies to the 2 mCherry reporter protein showed a faint band, corresponding to low expression levels of the 3 mature fusion protein (Figure 2A , TgPPR1-mCherry), but no signal was apparent by 4 fluorescence microscopy. When the endogenous PPR promoter was replaced by the inducible 5 t7s4 promoter, in cells designated i!TgPPR1-mCherry, a higher expression level of this PPR-6 fusion was seen by Western blot. Furthermore, two bands were present, of apparent sizes 7 consistent with the mature protein and a preprocessed PPR targeting intermediate still bearing 8 the predicted apicoplast targeting peptide ( Figure 2A ). The presence of these two bands is 9 characteristic for many apicoplast-targeted proteins (Waller et al., 2000) . Given the presence of 10 only the shorter, processed band when PPR1-mCherry fusion was expressed from the native 11 promoter, this would indicate near-complete processing under normal expression levels. To confirm apicoplast localization, we performed an immunofluorescence assay on the 15 i!PPR1-mCherry cells (green) co-stained with streptavidin-594 (red) which serves as an 16 apicoplast marker due to endogenous biotinylated apicoplast proteins (Chen et al., 2015) . Using 17 this cell line we could detect TgPPR1-mCherry location and observed it co-locating with the 18 apicoplast steptavidin marker ( Figure 2B ). We conclude that the PPR protein is localized to the 19 apicoplast, and is normally expressed at a very low level. 1 As PPR proteins in plants are known to be essential for chloroplast function, we tested if the 2 apicoplast PPR1 was also important for parasite growth. Knock-down of TgPPR1 in the 3 i!TgPPR1-mCherry line is induced by the addition of ATc, which represses the t7s4 promoter 4 required for PPR1 expression. ATc treatment of i!TgPPR1-mCherry showed rapid depletion of 5 TgPPR1-mCherry with the preprocessed protein undetectable within 12 hours of treatment, and 6 no protein detected after 48 hours by Western blot ( Figure 2C ). To test for a growth phenotype 7 with PPR1 depletion we used a i!TgPPR1 cell line (i.e. t7s4 promoter and no mCherry fusion). 8 Without ATc-induced depletion these cells showed normal growth by an eight-day plaque assay. 9 With ATc treatment no plaques were observed indicating a strong growth inhibition phenotype 10 in cells depleted of TgPPR1 ( Figure 2D ). This same growth inhibition phenotype was also seen 11 for i!TgPPR-mCherry with ATc treatment (not shown). 12 These results are consistent with TgPPR1 gene disruption being reported to have a negative 13 growth phenotype in a genome-wide CRISPR knockout screen (Sidik et al., 2016) . Similarly, in 14 Plasmodium berghei a recent genetic screen showed that the PPR1 orthologue 15 (PBANKA_1035800) is also essential to blood-stage growth (Bushell et al., 2017) . Together 16 these data suggest that the apicoplast PPR1 is broadly essential to apicomplexan parasites. 19 We then tested if PfPPR1 would bind apicoplast RNA transcripts. The recombinant PfPPR1 was Figure 3A . As a control, PPR protein was replaced by a DNA-binding protein from 11 Mycobacterium smegmatis (AmtR), which had been expressed and isolated using the same 12 procedure as PfPPR1 (Petridis et al.) . No binding to AmtR was seen. 1 We next sought to determine if PfPPR1 had a sequence-specific preference for RNA-binding. 2 Analysis of the PfPPR1 amino acid sequence using programs designed for the prediction of plant (Manley, 2013) . We constructed a SELEX library with a random 25 nucleotide sequence (N25) 8 in the middle of a 150 nucleotide RNA sequence (Manley, 2013) . After four rounds of selection 9 using recombinant His 6 -TRX-PfPPR1, sequences containing the motif UUAU were identified in 10 20 of the 50 final round clones ( Figure 3B ), with little sequence homology amongst the other 30 11 final round clones, suggesting a binding motif preferred by PfPPR1. This sequence motif 12 identified by SELEX is very similar to the UUAU apicoplast RNA processing site previously 13 identified (R. Ellen R. . 14 15 To confirm that PfPPR1 binds the RNA molecules containing the identified sequence motif, we 16 performed PPR pull-down assays using a range of biotinylated 150 nucleotide RNA molecules 17 as 'bait' for protein binding. The RNAs were obtained from in vitro transcription from five 18 clones isolated in the final round of the SELEX experiment above. RNAs 1, 4 and 5 contained 19 either one or two predicted PPR binding sites while RNA 2 contained a variation of the binding 20 site and RNA 3 lacked the binding site, as shown in Figure 3C . The biotin-labelled transcripts 21 were bound to streptavidin magnetic resin and incubated with recombinant His 6 -TRX-PfPPR1 in 22 a 2:1 protein:RNA molar ratio (as it has been reported to act as a dimer in plants). Western blots 23 were used to detect PPR protein bound to the 'bait' RNA. RNAs 4 and 5 showed strongest 24 bound PfPPR1 and each contained two of the consensus binding motifs ( Figure 3C ). RNAs 1 and 2 that contain slight variations of the consensus sites, UUAA and UUAC respectively, and 1 showed less bound PfPPR1. RNA 3 did not contain the consensus site and exhibited very weak 2 binding to PfPPR1 ( Figure 3C ). Thus, PfPPR1 binding correlated with presence and number of 3 the consensus binding motif. As a control, the PPR protein was replaced by the M. smegmatis 4 DNA binding protein (AmtR (Petridis et al.) ) which showed no binding to the RNA transcripts 5 ( Figure 3C ). We also repeated the experiment with the PfPPR1 protein minus the His 6 -TRX tag 6 and with an MBP tag instead of TRX to ensure that the tag on the PPR protein did not interfere 7 with RNA binding, and no difference in the results was seen (data not shown). 8 9 To further test the specificity of PfPPR1 for the UUAU consensus motif, and not elsewhere on 10 the RNA molecules we synthesized three 19 nucleotide RNA oligonucleotides with identical 11 flanking sequences but differing at the potential binding motif. RNA oligos 1 and 2 contained 12 the consensus binding sequence, followed by either an AA or a AU, while oligo 3 did not 13 contain the binding sequence (RNA oligo 1 UUAUAA, RNA oligo 2 UUAUAU, RNA oligo 3,
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UGACGA). Each RNA oligonucleotide was biotinylated at the 3' end and used to pull-down 15 PfPPR1 or M. smegmatis AmtR (control), as above. Western blot analysis showed that PfPPR1 16 was recovered from RNA oligos 1 and 2 binding assays, but not using RNA oligo 3. None of the 17 RNA oligos bound to AmtR ( Figure 3D ). Together, these results demonstrate PfPPR1 shows a 18 strong preference for binding RNA at UUAU. 19 20 PfPPR1 binds RNA as a dimer 21 bound to the PfPPR1 dimer ( Figure 4A ) (If PfPPR1 bound RNA as a monomer we would expect 10 the elution volume to be greater than 12.73 ml). The presence of the PfPPR1 protein in the 11 elution fraction was confirmed by SDS-PAGE ( Figure 4B ). The protein fraction was also treated 12 with Proteinase K and RNA extracted by phenol/chloroform treatment. When analyzed via 13 agarose gel electrophoresis, RNA was visible ( Figure 4C ). These data confirm binding of 14 PfPPR1 to the consensus RNA motif, and that this binding occurs as a PPR dimer. 1 As the RNA consensus motif is also associated with known transcript cleavage sites, the binding 2 of PfPPR1 was predicted to be able to protect RNA from degradation by ribonucleases. To test 3 for PfPPR1 protected footprints, we performed RNase protection assays. Three 150 nt RNA 4 molecules with either one or two consensus binding sites (RNAs 1, 4 and 5, as before) were pre-5 incubated with PfPPR1 protein and then incubated with the RNA endonuclease RNase A. In the 6 absence of PfPPR1 the transcripts were completely degraded by RNase A. However, with pre-7 incubation with PfPPR1, a small RNA fragment (less than 50 nucleotides) remained after RNase 8 A treatment in each ( Figure 5A ). We similarly tested for protection of three 19 nucleotide RNA 9 oligonucleotides (RNA oligos 1, 2, and 3, as before). No degradation was evident when the RNA 10 oligonucleotides 1 and 2 were incubated with PfPPR ( Figure 5B ). In contrast, RNA 11 oligonucleotide 3, which does not contain the binding sequence, was completely degraded by 12 RNase A in the presence of PfPPR1 ( Figure 5B ). These data show that PfPPR1 protects an RNA 13 region in a consensus binding motif-specific manner. The discovery of a genome of plastid origin in the malaria parasite Plasmodium twenty-five 2 years ago was a great surprise. Further investigation revealed the presence of small, but essential 3 organelle subsequently called the apicoplast. We now know a considerable amount about the 4 biochemistry and evolutionary history of this organelle. However, very little is known about how 5 the apicoplast genome itself is transcribed, or how post-transcriptional processing is regulated. 6 Here, we present the characterization of the single apicoplast pentatricopeptide repeat (PPR1) 7 protein and show that it is key to the regulation of post-transcriptional RNA processing. 8 9 PPR1 is a nucleus-encoded RNA-binding protein. We confirm that it is targeted to the apicoplast 10 in both Plasmodium and Toxoplasma. It is essential for normal growth in Toxoplasma, and is 11 highly likely also to be essential in Plasmodium (Bushell et al., 2017) . PPR1 is a P-class PPR 12 protein as it has no additional C-terminal domains and thus no catalytic function. It is 13 predominantly alpha helical in structure, contains 10 PPR motifs, and forms a dimer. 14 15 We show that the Plasmodium apicoplast PPR1 binds RNA at a UUAU-type motif. This motif is 16 found at known cleavage sites for Plasmodium apicoplast transcripts (R. Ellen R. Nisbet et al., 17 2016). We show that the protein binds in vitro to apicoplast RNA transcripts containing known 18 cleavage sites, and can protect RNA from degradation by RNase A. We have previously shown 19 that long, polycistronic RNA molecules are the primary form of transcription in the Plasmodium Alternatively, it could be that PfPPR1 is involved in recruiting the endonuclease activity 9 required to cleave RNA at the specific sites relevant to functional transcript production. In either 10 case, the coordination of PPR1 expression and apicoplast transcription is likely necessary for the 11 spike in apicoplast biosynthetic activity ahead of organelle segregation into schizonts to form the 12 next generation of infective merozoites. 13 14 Apicomplexan PPR1 is the first plastid PPR protein to be characterized outside the green 15 chloroplast lineage. Unlike other plant and algal taxa, there is only a single plastid PPR protein 16 in apicomplexan plastids. Apicoplast PPR1, like PPR proteins in plants and green algae, binds at 17 specific RNA sites, known to be the sites of RNA processing. A single and essential apicoplast 18 PPR protein in Plasmodium represents a very attractive target for the design of novel 19 antimalarial agents. PfPPR1 antibody production and purification 21 Recombinant PfPPR1 minus the His 6 -TRX tag was used to generate PfPPR1 antibodies in two 22 rabbits by Pacific Immunology. Pre-immune serum was taken followed by injection of recombinant PfPPR1 plus adjuvant. Four production bleeds were taken at 2 week intervals 1 followed by a final bleed after 3 months. 2 To purify the anti-PfPPR1 antibody, 150 µl His affinity resin was washed with 1 ml water and 3 three times with 1 x TBS pH 7.6. 250 µl of His 6 -TRX-PfPPR1 (1.7 mg/ml) was added and confocal microscope at 60 x magnification. Two channels, one to detect GFP fluorescence 16 (eGFP) and the other to detect AlexaFluor-568 fluorescence (Cy3) plus bright field were used to 17 image slides. Images were overlaid using Fluoview version 5.0 microscopy software. 18 T. gondii cell culture and generation of cell lines 19 T. gondii RH Δku80/TATi tachyzoites were grown by inoculation in confluent human foreskin 20 fibroblast (HFF) cells as previously described (Striepen, 2007) . Endogenous promoter replacement 21 with the t7s4 promoter was induced by Cas9-mediated cleavage at the 5' end of the ppr locus. 22 Plasmid pCRISPR/Cas9-GFP_PPR-sgRNA (see supplemental data) was assembled using the Golden protein gene mCherry was achieved using plasmid pPPR-mCherry_CAT (see supplemental data) 8 assembled using the Golden Gate method. Prior to transfection of parasites this plasmid was 9 linearized with BamHI, and transformants were selected with chloramphenicol and cloned by 10 limiting dilutions (Striepen, 2007) . 11 Toxoplasma PPR assays 12 Western blot detection of SDS-PAGE resolved whole cell lysates was performed using a rabbit anti-13 mCherry (1/1000 dilution) (Abcam) and anti-TOM40 as a control (Katris et al., 2014) . 14 Immunofluorescence microscopy was performed on intracellular tachyzoites using anti-mCherry 15 (1/1000) with secondary antibody AlexaFluor-488 Goat anti-rabbit IgG (Life technology). 16 Apicoplasts were co-stained with AlexaFluor-594 anti-Steptavidine (Life technology)(Chen et al., 17 2015). Samples were mounted with ProLong Diamond antifade mountant with DAPI (Invitrogen) 18 and sealed with nail polish. Cells were imaged using an Inverted Nikon Eclipse Ti microscope, a 19 Nikon objective lens (Plan APO, 100x/1.45 oil), and a Hamamatsu C11440, ORCA Flash 4.0 camera. 20 PPR knockdown was induced by addition of anhydrotetracycline (ATc) (0.5 µg/ml) to the growth 21 medium upon parasite inoculation of HFF cells. For growth assays extracellular parasites were 22 filtered, counted by haemocytometer, and 500 parasites added to 25 cm 2 tissue culture flasks 23 containing a confluent monolayer of HFF cells. To visualize plaque sizes in the presence or absence of ATc, flasks were aspirated, fixed with 5 ml 100% ethanol (5 minutes), stained with 5 ml crystal 1 violet solution (15 minutes) then washed once with phosphate-buffered saline (PBS) and dried before 2 imaging. 3 SELEX for determination of PfPPR1 RNA sequence specificity 4 A SELEX library was constructed as in (Manley, 2013) . SELEX using recombinant His 6 -TRX-5 PfPPR1 was carried out as per the protocol in (Manley, 2013) . Four rounds of selection were 6 performed, following which PCR products were cloned into pGEM-T easy (Promega) and 7 transformed into chemically competent E. coli DH5α and plated onto LB agar (100 µg/ml 8 ampicillin, 0.1 mM IPTG and 40 µg/ml X-gal). Plasmids were extracted from 50 clones and 9 sequenced. In addition, 10 input clones were sequenced from each round to determine 10 enrichment.
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Materials and Methods
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In vitro RNA Transcription and 3' End Biotinylation 12 Apicoplast P. falciparum apicoplast PCR products were obtained using the following primers: added. Ligation reactions were incubated overnight at 16 °C. 70 µl water was added followed by 21 100 µl chloroform:isoamyl alcohol (49:1). Reactions were centrifuged at 13 000 x g for three 22 minutes and the upper phase (aqueous layer) removed and transferred to a new tube. 10 µl 3 M 23 sodium acetate pH 5.2 and 250 µl 100% ethanol were added to precipitate RNA and stored at -20°C. The RNA was pelleted by centrifugation at 13 000 x g, 4 °C for 20 minutes, washed with 1 70% ethanol and centrifuged again. The pellet was resuspended in 20 µl water and RNA was 2 quantified with a Nanodrop-1000. 3 Biotinylated RNA-PfPPR1 Pull-downs 4 25 µl of resuspended streptavidin magnetic beads (Thermo Scientific) were washed in 1 ml 5 water and then three times in binding buffer (10 mM HEPES pH 7.5, 20 mM KCl, 1 mM MgCl 2 , 6 1 mM DTT) and resuspended in 20 µl binding buffer. 400 nM biotinylated RNA transcript was 7 added and incubated at 4 °C for 15 minutes. The beads were washed three times in 1 ml binding 8 buffer and resuspended in 20 µl binding buffer. 800 nM His 6 -TRX-PfPPR1 was added followed 9 by incubation at room temperature for 15 minutes with gentle agitation. The beads were washed 10 three times with 1 ml binding buffer and resuspended in 25 µl 4 x SDS loading dye, heated to 11 100 °C for 5 minutes and loaded onto a 4-15% SDS-PAGE gel (BioRad). Following PAGE, the 12 samples were transferred via wetblot to PVDF membrane for western blot analysis with a 13 mouse-anti His antibody and a secondary goat anti-mouse antibody conjugated with HRP. 14 Western blots were visualized using Western Bright Quantum (Advasnsta) chemiluminiscent 15 substrate and exposed using a CCD camera (Genebox). 16 Gel Filtration Chromatography 17 His 6 -TRX-PfPPR1 was incubated with RNA transcripts in a 1:1 molar ratio in 1 x binding buffer RNase A protection assays 23 10 µM RNA, 1 x binding buffer buffer (10 mM HEPES pH 7.5, 20 mM KCl, 1 mM MgCl 2 and 1 1 mM DTT) and 10 µM PfPPR1 in a volume of 20 µl were incubated for 15 minutes at room 2 temperature, followed by addition of 0.01% (v/v) 20 mg/ml RNase A and incubated at 37 °C 3 with shaking for 30 minutes. Reactions were stopped by the addition of 10 µl 2 x formamide 4 loading dye (95% formamide, 0.025% w/v bromophenol blue, 0.025% xylene cyanol FF, 5 mM 5 EDTA) and heating to 70 °C for 5 minutes. Assay reactions were analyzed by 12% urea-6 denaturing PAGE gel, and visualized with SYBR Safe nucleic acid stain. Three controls (no 7 PfPPR1, no RNA, no RNase) were carried out, where the reagent was replaced by water. 
